We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Varian Acquires IonSpec

By Biotechdaily staff writers
Posted on 10 Mar 2006
Varian, Inc. (Palo Alto, CA, USA) has acquired IonSpec Corp. (Lake Forest, CA, USA) for approximately U.S.$16 million.

Varian said the acquisitions of IonSpec's Fourier transform mass spectrometry (FTMS) technology represents a significant step toward expanding its information-rich detection (IRD) portfolio.

Varian expects the acquisition to increase its development of growing life science applications, specifically the study of proteins, nucleic acids, and drug metabolites. The initial cash purchase price includes paying down assumed debt and an opportunity for an additional payment if FTMS products reach specified financial targets over a three-year period.

FTMS instruments are used in laboratories worldwide to determine the function and structural characterization of proteins and other biomolecules in various biologic systems.




Related Links:
Varian
IonSpec

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automated Clinical Chemistry Analyzer
Envoy 500+
Immunofluorescence Analyzer
IFA System

Latest BioResearch News

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
10 Mar 2006  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
10 Mar 2006  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
10 Mar 2006  |   BioResearch